Company intelligence / Profile preview

Yaso Therapeutics

Frisco, Texas, United Statesyasotherapeutics.com ↗

Ownership: Private
Development stage: Phase 1

Overview

Yaso Therapeutics is developing topical drug products containing PPCM to treat and prevent all drug-resistant strains of gonorrhea and herpes simplex, as well as to prevent unplanned pregnancies. The company has secured worldwide rights to PPCM and has advanced at least one product from benchtop research to an authorized IND. As of March 2025, its lead programs are in preclinical or early clinical stages.[1][4][5][6]

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: Small molecules (specifically polyanionic drugs such as PPCM)
Industry: Biotech

Drug pipeline

1 asset

YASO GEL

Beyond the preview

Go deeper on Yaso Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaso Therapeutics.

Explore the full profile